Highly expressed in metastatic tumors.Overexpression is associated with poorer overall, disease free and metastatic free survival.Linked with increased tumor grade.RHAMM overexpression increased migration of breast cancer cells.Associated with increased breast cancer risk in BRCA1 mutation carriers. This evidence concerns the gene BRCA1 and breast cancer.